Stay updated with breaking news from Northstar Rx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sun Pharma is recalling 55,000 bottles of Febuxostat Tablets, in 40 mg and 80 mg strengths, from the American market due to manufacturing practice deviations caused by microbial contamination at their Dadra-based plant.
Sun Pharma recalls Febuxostat Tablets in 40 mg and 80 mg strengths from US market.
The New Jersey-based unit of the Mumbai-based drug major is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.
Drug major Sun Pharma is recalling around 55,000 bottles of a generic medication to treat gout from the American market due to manufacturing practices norms deviations, according to the US health regulator. The New Jersey-based unit of the Mumbai-based drug major is recalling Febuxostat Tablets in
Hydroxychloroquine Market Report Covers Future Trends with Research 2023–2031